Try our beta test site
1 study found for:    NCT01313962
Show Display Options
Rank Status Study
1 Completed Safety Study of Flufirvitide-3 Nasal Spray in Healthy Subjects
Condition: Influenza
Interventions: Drug: Flufirvitide-3 0.05 mg single dose;   Drug: Flufirvitide-3, 0.1 mg single dose;   Drug: Flufirvitide-3, 0.2 mg single dose;   Drug: Flufirvitide-3, 0.4 mg single dose;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.